KPC Pharmaceuticals Inc
600422
Company Profile
Business description
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Contact
No. 166 Keyi Road
State New and High-Technology Development Zone
KunmingYunnan650106
CHNT: +86 8718319868
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
5,051
Stocks News & Analysis
stocks
Ask the analyst: Can this big Covid loser scale its former heights?
Corporate Travel Management saw its profits fall through the floor during the pandemic. Our analyst Brian Han answers a reader question on what might be next.
stocks
The fight for Insignia continues
Numerous acquisition proposals vindicate Insignia's improved earnings momentum.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.40 | 31.30 | 0.36% |
| CAC 40 | 7,970.86 | 78.25 | 0.99% |
| DAX 40 | 21,504.92 | 93.39 | 0.44% |
| Dow JONES (US) | 44,565.07 | 408.34 | 0.92% |
| FTSE 100 | 8,536.57 | 28.63 | -0.33% |
| HKSE | 20,066.19 | 365.63 | 1.86% |
| NASDAQ | 20,053.68 | 44.34 | 0.22% |
| Nikkei 225 | 39,931.98 | 26.89 | -0.07% |
| NZX 50 Index | 13,024.70 | 35.38 | -0.27% |
| S&P 500 | 6,118.71 | 32.34 | 0.53% |
| S&P/ASX 200 | 8,408.90 | 30.20 | 0.36% |
| SSE Composite Index | 3,252.63 | 22.46 | 0.70% |